Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

NCT05065736 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer
Carcinoma
Adenocarcinoma

Interventions

DRUG: 18F-Clofarabine

Sponsor

Roberto Vargas